168 related articles for article (PubMed ID: 27581838)
1. Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.
Dullaart RP; Garcia E; Jeyarajah E; Gruppen EG; Connelly MA
Lipids Health Dis; 2016 Aug; 15(1):143. PubMed ID: 27581838
[TBL] [Abstract][Full Text] [Related]
2. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease.
Nass KJ; van den Berg EH; Gruppen EG; Dullaart RPF
Eur J Clin Invest; 2018 Sep; 48(9):e12988. PubMed ID: 29947103
[TBL] [Abstract][Full Text] [Related]
3. Plasma angiopoietin-like 4 is related to phospholipid transfer protein activity in diabetic and non-diabetic subjects: role of enhanced low grade inflammation.
Gruppen EG; Kersten S; Dullaart RPF
Lipids Health Dis; 2018 Mar; 17(1):60. PubMed ID: 29587751
[TBL] [Abstract][Full Text] [Related]
4. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
Riemens SC; Van Tol A; Stulp BK; Dullaart RP
J Lipid Res; 1999 Aug; 40(8):1467-74. PubMed ID: 10428983
[TBL] [Abstract][Full Text] [Related]
5. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.
Dallinga-Thie GM; van Tol A; Dullaart RP;
Biochim Biophys Acta; 2009 Aug; 1791(8):714-8. PubMed ID: 19303940
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
Dullaart RPF; Gruppen EG; Dallinga-Thie GM
Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
[TBL] [Abstract][Full Text] [Related]
8. Higher high density lipoprotein cholesterol associated with moderate alcohol consumption is not related to altered plasma lecithin:cholesterol acyltransferase and lipid transfer protein activity levels.
Riemens SC; van Tol A; Hoogenberg K; van Gent T; Scheek LM; Sluiter WJ; Dullaart RP
Clin Chim Acta; 1997 Feb; 258(1):105-15. PubMed ID: 9049447
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities.
Riemens SC; Van Tol A; Sluiter WJ; Dullaart RP
J Lipid Res; 1999 Aug; 40(8):1459-66. PubMed ID: 10428982
[TBL] [Abstract][Full Text] [Related]
10. Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).
Pahl MV; Ni Z; Sepassi L; Moradi H; Vaziri ND
Nephrol Dial Transplant; 2009 Aug; 24(8):2541-6. PubMed ID: 19297356
[TBL] [Abstract][Full Text] [Related]
11. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.
Dullaart RP; De Vries R; Scheek L; Borggreve SE; Van Gent T; Dallinga-Thie GM; Ito M; Nagano M; Sluiter WJ; Hattori H; Van Tol A
Scand J Clin Lab Invest; 2004; 64(3):205-15. PubMed ID: 15222630
[TBL] [Abstract][Full Text] [Related]
13. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
[TBL] [Abstract][Full Text] [Related]
14. Pre-β-HDL formation relates to high-normal free thyroxine in type 2 diabetes mellitus.
van Tienhoven-Wind LJ; Perton FG; Dullaart RP
Clin Biochem; 2016 Jan; 49(1-2):41-6. PubMed ID: 26320015
[TBL] [Abstract][Full Text] [Related]
15. Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.
Dullaart RP; Perton F; Kappelle PJ; de Vries R; Sluiter WJ; van Tol A
Biochim Biophys Acta; 2010 Jan; 1801(1):84-8. PubMed ID: 19800416
[TBL] [Abstract][Full Text] [Related]
16. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
[TBL] [Abstract][Full Text] [Related]
17. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
[TBL] [Abstract][Full Text] [Related]
18. Diabetes induces gender gap on LCAT levels and activity.
Nakhjavani M; Morteza A; Karimi R; Banihashmi Z; Esteghamati A
Life Sci; 2013 Jan; 92(1):51-4. PubMed ID: 23142243
[TBL] [Abstract][Full Text] [Related]
19. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
[TBL] [Abstract][Full Text] [Related]
20. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects.
de Vries R; Kappelle PJ; Dallinga-Thie GM; Dullaart RP
Atherosclerosis; 2011 Jul; 217(1):253-9. PubMed ID: 21481395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
